Merck & Co., Inc.
MRK · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $210 | $198 | $226 | $253 |
| - Cash | $18 | $8 | $9 | $13 |
| + Debt | $41 | $35 | $35 | $38 |
| Enterprise Value | $233 | $226 | $252 | $278 |
| Revenue | $17 | $16 | $16 | $16 |
| % Growth | 9.3% | 1.8% | -0.6% | – |
| Gross Profit | $14 | $12 | $12 | $12 |
| % Margin | 81.9% | 77.5% | 78% | 75.5% |
| EBITDA | $8 | $6 | $7 | $6 |
| % Margin | 47.1% | 40.6% | 47.1% | 36.5% |
| Net Income | $6 | $4 | $5 | $4 |
| % Margin | 33.5% | 28% | 32.7% | 24% |
| EPS Diluted | 2.32 | 1.76 | 2.01 | 1.48 |
| % Growth | 31.8% | -12.4% | 35.8% | – |
| Operating Cash Flow | $8 | $3 | $3 | $3 |
| Capital Expenditures | -$1 | -$1 | -$1 | -$1 |
| Free Cash Flow | $7 | $3 | $1 | $3 |